▶주메뉴 바로가기
▶본문 바로가기
SillaJen aims to secure around 220 billion won (US$194.89 million) fresh funds through issuing convertible bonds, according to industry sources on March 7. It has picked Kium Securities to organize ...
Stock exchange operator Korea Exchange has blocked condom maker Bio Genetics from getting representation on Kyung Nam Pharm’s board, according to industry sources on Mar. 6. Bio Genetics, which boug...
Korean biopharmaceutical firm Samsung Bioepis said on March 5 it has won approval from European authorities for the sale of mass dosages of its biosimilar drug Ontruzant. The European Medicines A...
Hypertension drugs gained unwanted attention in South Korea last year: More than 170 generic drugs sold by 76 local drugmakers were recalled by the Drug Ministry for their inclusion of valsartan, a c...
Ildong Pharmaceutical’s multivitamin series Aronamin was the best-selling over the counter drug for the third consecutive year in 2018. OTC drugs can be purchased directly at medical stores without ...
Korean cosmetics manufacturer Kolmar Korea has decided to issue corporate bonds worth 100 billion won (US$89.35 million), according to industry sources on Feb. 28. Mirae Asset Daewoo is organizing i...
Celltrion Pharm, the generic arm of Celltrion, announced on Feb. 27 that it has decided to inject 58.2 billion won for establishing its Remsima SC production facility at its plant in Cheongju, North ...
SK Biopharmaceuticals, the new drug development unit of Korea’s telecom-to-energy conglomerate SK Group, is considering exporting its drug candidate Cenobamate to Japan, according to industry sources...
Hong Kong-based global private equity firm Anchor Equity Partners plans to sell its 47 percent stake in Korean top drug retailer Geoyoung, according to industry sources on Feb. 25. The PEF has repor...
Kyung Nam Pharm, a local drug maker known for its vitamin supplement product Lemona, is once again looking for an owner after failing to sign a deal with South Korean media company KMH Group in 2018....
Korean pharmaceutical company Yuhan announced on Feb. 20 that its sales reached 1.5 trillion won (US$1.3 billion) last year, up 4 percent from the previous year. Yuhan has now become the first Korea...
Koreas intravenous solution maker JW Life Science announced on Feb. 18 that it has decided to give 500 won (US$0.44) dividend per share, which amounts to around 7.91 billion won in total. Establishe...
Korean drug maker Kwangdong Pharmaceutical, which has been focusing on diversifying its business portfolio, appears to be making attempts at a turnaround amid its slumping global business. The Korea...
SK Biopharmaceuticals, the new drug development subsidiary of South Korean conglomerate SK Group, announced on Feb. 14 that it had signed a deal worth US$530 million with Swiss drug company Arvelle T...
CJ Healthcare announced on Feb. 13 that it has signed a deal worth US$84 million with Mexico-based Laboratorios Carnot to exclusively supply its drug Tegoprazan for the next 10 years. Tegoprazan, wh...
Netmarble Q2 net more than doubles on new games
Notion unveils Korean version to tap into 2nd-largest market
Gooroome lands W2b in pre-A round funding
Talks for HDC-Asiana deal likely to prolong
LG U+ to roll out 5G-powered AR glass service with Nreal
HMM sells stake in Algeciras terminal
SK makes world’s 1st NCM battery with 90% nickel
STIC Investments, Amorepacific and more - this week’s startup and investment update
August 12, 2020
